Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Loss and Comprehensive Loss (Unaudited)

v3.21.1
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
EXPENSES    
Research and development $ 5,642 $ 1,541
General and administrative 2,342 1,816
Total operating expenses 7,984 3,357
OTHER INCOME (EXPENSE)    
Interest income 8 42
Other expenses (23) (5)
Total other income (expense) (15) 37
Net loss and comprehensive loss $ (7,999) $ (3,320)
Basic and diluted net loss per common share $ (1.30) $ (2.15)
Weighted average shares used in computation of basic and diluted net loss per common share 6,131,821 1,546,839